Please use this identifier to cite or link to this item:
https://oxfordhealth-nhs.archive.knowledgearc.net/handle/123456789/1052
Title: | Ketamine for suicidal ideation: New trial challenges current thinking about ketamine |
Authors: | De Giorgi, Riccardo Medical Trainee |
Keywords: | Suicide |
Issue Date: | Feb-2022 |
Citation: | Riccardo De Giorgi. Ketamine for suicidal ideation: New trial challenges current thinking about ketamine. BMJ 2022;376:o74 |
Abstract: | Will ketamine be given to eligible patients with suicidal ideation any time soon? This is hard to say, given the plausible concern that the widespread use of ketamine might trigger a new opioid style crisis.10 Whether ketamine reduces suicidal ideation in some people is a matter of evidence —which this trial by Abbar and colleagues provides. But whether the emergency use of ketamine for suicidal crises will be recommended in practice depends on many other factors, including the values and preferences of patients, clinicians, researchers, and policymakers. |
Description: | Open Access |
URI: | https://oxfordhealth-nhs.archive.knowledgearc.net/handle/123456789/1052 |
Appears in Collections: | Self Harm and Suicide |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.